LBC Advisors Life Science & Biopharm Advisory & Management
LBC AdvisorsLife Science & Biopharm Advisory & Management

About Rainer


Dr. Rainer Lichtenberger, MBA, CEO



Synopsis Business Acumen and Experience


Energetic, resultsoriented and accomplished, with over 25

years’ international experience in senior global appointments

in biotech, biopharmaceutical & life science companies,

with most recent tenures as CEO , Managing Director and Executive VP.

Successful set-up and spin-off of project- and technology-focused

companies and establishing high-performance teams to

set and execute business plans. Attracted and managed

venture capital in excess of 100 Mio. € in several companies,

from seed funding to clinical-stage growth financing.

Co-led exits in excess of €400m.value.


Analytical skills and experience – Extensive, successful negotiation and

deal making experience in technology and product

acquisitions resp. divestments for pharmaceutical and biotech industry.
Directly responsible for over €100 million in upfront deal and multiples in pending

milestones and royalties.

Broad global network, with senior level contacts

in top-tier US and EU biotech and pharmaceutical companies.


since 2015



2008 - 2014

Founder & CEO
Atriva Therapeutics GmbH, Tübingen (D)

CEO & Managing Director

CEVEC Pharmaceuticals GmbH, Cologne (D)

2004 2008

President and CEO

Neuraxo Biopharmaceuticals GmbH, Erkrath, (D)

Since 2004

Founder & CEO

LBC Advisors LP

2002 – 2004

Member of the Executive Commitee,

Business Development & International Marketing,

Merckle-ratiopharm group

1998 – 2002                

VP Global Strategic Marketing Pharma

Merck KGaA Darmstadt (D)


Meet LBC at these conferences:



BioTechnologietage 2024



Druckversion | Sitemap
© LBC Advisors